Upadacitinib Rapidly Improves Patient-Reported Outcomes in Atopic Dermatitis: 16-Week Results from Phase 3 Clinical Trials (Measure Up 1 and 2)

Abstract Introduction Atopic dermatitis (AD) is characterized by intense itch and other symptoms that negatively impact quality of life (QoL). This study evaluates the effect of upadacitinib (an oral selective Janus kinase inhibitor) monotherapy on patient-reported outcomes (PROs) among adults and a...

Full description

Saved in:
Bibliographic Details
Main Authors: Eric L. Simpson (Author), Vimal H. Prajapati (Author), Yael A. Leshem (Author), Raj Chovatiya (Author), Marjolein S. de Bruin-Weller (Author), Sonja Ständer (Author), Andrew E. Pink (Author), Brian M. Calimlim (Author), Wan-Ju Lee (Author), Henrique Teixeira (Author), Barry Ladizinski (Author), Xiaofei Hu (Author), Yang Yang (Author), Yingyi Liu (Author), Meng Liu (Author), Ayman Grada (Author), Andrew M. Platt (Author), Jonathan I. Silverberg (Author)
Format: Book
Published: Adis, Springer Healthcare, 2024-05-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available